Early Outcome of a Phase I/II Clinical Trial (NCT03538899) of Gene-Corrected Autologous CD34+ Hematopoietic Cells and Low-Exposure Busulfan in Newly Diagnosed Patients with Artemis-Deficient Severe Combined Immunodeficiency (ART-SCID)
暂无分享,去创建一个
J. Puck | R. McIvor | H. Malech | A. Petrovič | Jason S. L. Yu | C. Dvorak | M. Cowan | C. Fraser-Browne | Misako Kawahara | J. Long-Boyle | L. Broderick | D. Hu | D. Punwani | Jasmeen S Dara | Ukina R. Sanford | J. Facchino | H. Miller | Shivali Chag | Jess Oh | S. Teoh | Janelle Facchino | Carol Fraser-Browne